Who Exports Methylprednisolone from India — 355 Suppliers Behind a $29.3M Market
India's methylprednisolone export market is supplied by 355 active exporters who collectively shipped $29.3M across 2,492 shipments. PAR FORMULATIONS PRIVATE LIMITED leads with a 28.2% market share, followed by ZYDUS LIFESCIENCES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED. The top 5 suppliers together control 65.5% of total export value, reflecting a concentrated market structure.
Top Methylprednisolone Exporters from India — Ranked by Export Value
PAR FORMULATIONS PRIVATE LIMITED is the leading methylprednisolone exporter from India, holding a 28.2% share of the $29.3M market across 2,492 shipments from 355 exporters. The top 5 suppliers — PAR FORMULATIONS PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, MYLAN LABORATORIES LIMITED, SWISS PARENTERALS LIMITED — collectively control 65.5% of total export value, indicating a moderately concentrated market. Individual shares are: PAR FORMULATIONS PRIVATE LIMITED (28.2%), ZYDUS LIFESCIENCES LIMITED (13.7%), EUGIA PHARMA SPECIALITIES LIMITED (10.1%), MYLAN LABORATORIES LIMITED (8.9%), SWISS PARENTERALS LIMITED (4.5%).
Top Methylprednisolone Exporters from India
Ranked by export value · 355 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | PAR FORMULATIONS PRIVATE LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $8.3M | 1 | 28.2% |
| 2 | ZYDUS LIFESCIENCES LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $4.0M | 1 | 13.7% |
| 3 | EUGIA PHARMA SPECIALITIES LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $3.0M | 1 | 10.1% |
| 4 | MYLAN LABORATORIES LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $2.6M | 1 | 8.9% |
| 5 | SWISS PARENTERALS LIMITED PDSOLONE 40 MG METHYLPREDNISOLONE AS MESOLOPRED INJECTION - METHYLPREDNISOLONESOLOPRED 4 - METHYLPREDNISOLONE TABLET 4 | $1.3M | 11 | 4.5% |
| 6 | CARITAS HEALTHCARE PRIVATE LIMITED METHYLPREDNISOLONE SODIUM SUCCINATE FOR | $1.1M | 1 | 3.9% |
| 7 | STERISCIENCE SPECIALTIES PRIVATE LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $879.7K | 1 | 3.0% |
| 8 | CADILA HEALTHCARE LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $763.0K | 1 | 2.6% |
| 9 | AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $647.1K | 1 | 2.2% |
| 10 | TROIKAA PHARMACEUTICALS LIMITED METHYLPREDNISOLONE SODIUM SUCCINATE FORMETHPRED 500MG METHYLPREDNISOLONE SODIUMMETHPRED 1GM METHYLPREDNISOLONE SODIUM S | $458.8K | 3 | 1.6% |
| 11 | UNITED BIOTECH PRIVATE LIMITED METHYLPREDNISOLONE SODIUM SUCCINATE FOR | $429.2K | 12 | 1.5% |
| 12 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED METAPREDNILON 4 MG TABLETS 3X10`SMETAPREDNILON 16 MG 3X10`S | $373.5K | 2 | 1.3% |
| 13 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED METHYLPREDNISOLONE ACETATE INJSUSPENSIONMETHYLPREDNISOLONE TAB USP 4 MG - 1 X 21METHYLPREDNISOLONE ACETATE INJECTABLE SU | $336.0K | 1 | 1.1% |
| 14 | CAPLIN POINT LABORATORIES LIMITED METHYLPREDNISOLONE SODIUM SUCCINATE FORMETHYLPREDNISOLONE SODIUM SUCCINATE FORINJECTION USP 125MG | $311.4K | 4 | 1.1% |
| 15 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED PDSOLONE 40 MG METHYLPREDNISOLONE AS MESOLOPRED INJECTION - METHYLPREDNISOLONESOLOPRED 4 - METHYLPREDNISOLONE TABLET 4 | $281.7K | 8 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Methylprednisolone exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Zydus Lifesciences Limited | Approved | Yes | Yes | Multiple | Zydus Lifesciences, formerly Cadila Healthcare, has received FDA approvals and h |
| Mylan Laboratories Limited | Approved | Yes | Yes | Multiple | Mylan Laboratories has obtained FDA approvals and maintains WHO-GMP and EU GMP c |
| Cadila Healthcare Limited | Warning Letter, October 2 | Yes | Yes | Multiple | Cadila Healthcare received an FDA warning letter in October 2019 but holds WHO-G |
| Amneal Pharmaceuticals Private Limited | Approved | Yes | Yes | Multiple | Amneal Pharmaceuticals has received FDA approvals and holds WHO-GMP and EU GMP c |
| Intas Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | Intas Pharmaceuticals has obtained FDA approvals and maintains WHO-GMP and EU GM |
| Alembic Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | Alembic Pharmaceuticals has received FDA approvals and holds WHO-GMP and EU GMP |
| Glenmark Pharmaceuticals Limited | Warning Letter, July 2025 | Yes | Yes | Multiple | Glenmark Pharmaceuticals received an FDA warning letter in July 2025 but holds W |
| Hikal Limited | Warning Letter, August 20 | Yes | Yes | Multiple | Hikal Limited received an FDA warning letter in August 2025 but holds WHO-GMP an |
| Kenil Healthcare Private Limited | Warning Letter, June 2025 | Yes | Yes | Multiple | Kenil Healthcare received an FDA warning letter in June 2025 but holds WHO-GMP a |
TransData Nexus reviewed the regulatory standing of 9 leading Methylprednisolone exporters from India. 5 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. 4 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Methylprednisolone sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of Active Pharmaceutical Ingredients (APIs). The city's pharmaceutical ecosystem is bolstered by a robust infrastructure, skilled workforce, and supportive government policies. This concentration of API manufacturers makes Hyderabad a critical hub for sourcing raw materials essential for Methylprednisolone production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat has emerged as a leading center for pharmaceutical formulations. Companies like Zydus Lifesciences Limited, headquartered in Ahmedabad, have significantly contributed to this region's prominence. Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company engaged in the manufacturing of generic drugs. The region's focus on formulations, coupled with a strong regulatory framework, ensures the production of high-quality Methylprednisolone products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for Indian pharmaceuticals. This region's proximity to major ports facilitates efficient international distribution. Pharmaceutical companies in this area benefit from well-established logistics networks, enabling timely and cost-effective export of Methylprednisolone to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has become a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives and supportive state policies. The region hosts numerous manufacturing units, contributing to the production capacity of drugs like Methylprednisolone. The cost advantages and regulatory support make this cluster attractive for pharmaceutical production.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical expertise and regulatory compliance of suppliers, especially those in Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Leverage Export Infrastructure: Utilize the logistical advantages of the Mumbai-Thane-Raigad region to streamline international shipments.
- Consider Cost Benefits: Explore manufacturing partnerships in the Baddi-Nalagarh cluster to take advantage of tax incentives and cost efficiencies.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can optimize its Methylprednisolone supply chain, ensuring quality, cost-effectiveness, and reliability.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Methylprednisolone exporters from India
Eris Lifesciences Limited — Eris Lifesciences acquires 51% stake in Swiss Parenterals
Eris Lifesciences Limited acquired a 51% equity stake in Swiss Parenterals Limited for ₹637.50 crore, expanding its sterile injectable footprint and entering the Rest of the World export markets. IMPACT: This acquisition is expected to enhance Eris Lifesciences' capabilities in sterile injectables, potentially increasing Methylprednisolone exports.
Impact: This acquisition is expected to enhance Eris Lifesciences' capabilities in sterile injectables, potentially increasing Methylprednisolone exports.
Eris Lifesciences Limited — Eris Lifesciences acquires remaining 30% stake in Swiss Parenterals
Eris Lifesciences Limited acquired the remaining 30% stake in Swiss Parenterals Limited for ₹423.30 crore, making it a wholly owned subsidiary. IMPACT: Full ownership may lead to streamlined operations and increased Methylprednisolone export capacity.
Impact: Full ownership may lead to streamlined operations and increased Methylprednisolone export capacity.
Zydus Lifesciences Limited — Zydus partners with Bioeq for NUFYMCO commercialization
Zydus Lifesciences' subsidiary partnered with Bioeq AG to commercialize NUFYMCO, a biosimilar of Lucentis (Ranibizumab), in the U.S. market. IMPACT: While focused on ophthalmology, this collaboration may enhance Zydus' overall export capabilities, indirectly affecting Methylprednisolone exports.
Impact: While focused on ophthalmology, this collaboration may enhance Zydus' overall export capabilities, indirectly affecting Methylprednisolone exports.
Common Questions — Methylprednisolone Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which methylprednisolone supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, PAR FORMULATIONS PRIVATE LIMITED leads with 44 recorded shipments worth $8.3M. ZYDUS LIFESCIENCES LIMITED (127 shipments) and EUGIA PHARMA SPECIALITIES LIMITED (32 shipments) are also established high-volume exporters.
Q How many methylprednisolone manufacturers are there in India?
India has 355 active methylprednisolone exporters with a combined export market of $29.3M across 2,492 shipments to 128 countries. The top 5 suppliers hold 65.5% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for methylprednisolone from India?
Average FOB unit price: $19.41 per unit, ranging from $0.01 to $1174.41. Average shipment value: $11.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 355 verified Indian exporters of Methylprednisolone ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,492 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 128 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,492 Verified Shipments
355 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists